Clinical Trials Directory

Trials / Conditions / Diabetic Nephropathy Type 2

Diabetic Nephropathy Type 2

29 registered clinical trials studyying Diabetic Nephropathy Type 2 — 9 currently recruiting.

StatusTrialSponsorPhase
RecruitingSafety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patient
NCT07396155
PT. Prodia Stem Cell IndonesiaPhase 1 / Phase 2
Not Yet RecruitingResearch on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropa
NCT07459946
Jiazhen YinN/A
Not Yet RecruitingRelationship of Serum Zinc Level With Severity of Diabetic Nephropathy
NCT06690034
Assiut University—
RecruitingClinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
NCT06586203
OptitheraN/A
CompletedSalivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status
NCT07498894
Pamukkale University—
CompletedEffect of Exercise Therapy on Type II Diabetic Neuropathic Patients
NCT06332378
Dr. Sobia HasanN/A
Not Yet RecruitingEffect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective,
NCT06222476
Yan BiN/A
Not Yet RecruitingStudy of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropat
NCT06068439
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 / Phase 3
UnknownComparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic K
NCT05373004
Omar Tarek ElfarargiPhase 2 / Phase 3
RecruitingMultidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Ne
NCT05888909
Chinese PLA General Hospital—
CompletedImpact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
NCT06326034
Mohammed Mahmood MohammedPhase 4
RecruitingResearch on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
NCT06833541
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine—
CompletedInvestigational and Comparative Study in the Management of Diabetic Nephropathy
NCT05487755
Tanta UniversityPhase 3
UnknownRelationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
NCT04962399
Zheng Guo—
RecruitingScreening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
NCT04931537
Second Affiliated Hospital, School of Medicine, Zhejiang University—
Active Not RecruitingAtrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920
Novartis PharmaceuticalsPhase 2
CompletedSleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
NCT04549324
University of Aarhus—
TerminatedPatient-Derived Stem Cell Therapy for Diabetic Kidney Disease
NCT03840343
Mayo ClinicPhase 1
UnknownObservational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
NCT03859817
University of Milan—
UnknownEfficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
NCT04143412
Beni-Suef UniversityPhase 2
Completedthe Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD
NCT03681704
Shanghai University of Traditional Chinese MedicinePhase 1
Completedthe Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD
NCT03681249
Shanghai University of Traditional Chinese MedicineEARLY_Phase 1
UnknownSafety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
NCT03502031
James A. Tumlin, MDPhase 4
UnknownT-regulatory Cells in Diabetic Type Two Nephropathy
NCT03591939
Assiut University—
UnknownGreen Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy
NCT03622762
Centro Universitario de Ciencias de la Salud, MexicoPhase 2
CompletedDietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
NCT03889236
Leiden University Medical CenterN/A
CompletedGlycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis
NCT03909269
Rigshospitalet, Denmark—
WithdrawnRotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
NCT03504566
Steno Diabetes Center CopenhagenPhase 4
UnknownExtracorporeal Low-intensity Shockwave in Diabetic Nephropathy
NCT03445247
Chang Gung Memorial HospitalN/A